Inflazome

Roche pays €380M for NLRP3 biotech Inflazome, claiming a leading position in hot field
Fierce Biotech
Mon, 09/21/20 - 10:28 am
Roche
M&A
Inflazome
inflammatory disease
Inflazome grabs Fox Foundation funding for Parkinson’s R&D
Fierce Biotech
Mon, 03/25/19 - 10:26 am
Inflazome
Parkinson's Disease
R&D
Inflazome Completes $45 Million Series B Round
CP Wire
Mon, 11/19/18 - 09:47 am
Inflazome
inflammation
Inflazome Completes $45 Million Series B Round
Mon, 11/19/18 - 09:19 am
Inflazome